Small amounts (1 standard drink) with food are generally safe for most patients, but risks include hypoglycaemia, delayed absorption (leading to over-drinking), dehydration, and increased pancreatitis risk
Severe cases may require the administration of activated charcoal to limit further absorption
The American Diabetes Association (ADA) guidelines recommend GLP-1 receptor agonists as preferred agents for patients with type 2 diabetes who have established atherosclerotic cardiovascular disease or indicators of high cardiovascular risk, or for those requiring additional glucose-lowering beyond metformin
[Laughs.] Pierre-Louis: And over the past, you know, 15, 20 years, these drugs have been seen as useful for type 2 diabetes and weight loss
Living Well With Semaglutide and Tirzepatide For many Miami residents, GLP-1 medications represent not just clinical improvement but a path toward reconnecting with aspects of life that chronic health conditions had diminished
No independent third-party review platform, star rating, or review count was identified in the materials reviewed for this article